The aim is to place healthy hepatic cells into biodegradable biopolymers (such as poly-lactide-co-glycolide), implant them into laboratory animals and demonstrate that the cells survive and function in these animals.
Based on cannabis metabolomics, cannabis smoke-analysis and advanced extraction techniques, tailor-made well-defined extractions will be made for different medical applications and new techniques for oral admin will be developed.
Development of a new, innovative medical apparatus for the artificial ventilation of lungs of intensive care patients and as extra support during emergencies (e.G. Terrorist attack or natural disaster).
A new system of imaging of cardiac viability by resonance imaging. Comparative study with other diagnostic techniques.
Efficient control strategies against phytoplasma vectoring psyllids will be established by the help of molecular markers to study their life cycle, by determining the transmission parameters and by developing disturbation strategies.
To develop, manufacture, test and introduce to the market a completely new type of medical device for vacuum therapy.
Personalised medicine has been targeted as the most important future development in both medicine and drug development. The final product that synergistically combines the two companies' capabilities will be a software platform.
Increasing the bioavailability and targeted delivery of active ingredients - curcumin.
We will explore a novel type of cavvine against food allergy by designing a vaccine with an antibody-like structure using recombinant allergen and a targeting unit. Canditate molecules will be tested in-vitro and in an animal model.
This project, promoted by genibet, ibet and nvgh aims to implement the gmp production processes of two conjugated antigens (vi/crm197 and o/crm197) that will incorporate a bivalent vaccine against typhoid and paratyphoid enteric fevers.